Gilead Sciences reported $3.53B in Operating Expenses for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Acorda Therapeutics ACOR:US $ 57.64M 58.91M
Agios Pharmaceuticals AGIO:US $ 91.22M 45.26M
Alexion Pharmaceuticals ALXN:US $ 1000.3M 30.6M
Alnylam Pharmaceuticals ALNY:US $ 363.82M 6.04M
Amgen AMGN:US $ 3.77B 854M
Arena Pharmaceuticals ARNA:US $ 131.99M 9.61M
Biogen BIIB:US $ 2289.3M 569.2M
Biomarin Pharmaceutical BMRN:US $ 460.94M 36.01M
Bluebird Bio BLUE:US $ 244M 29.31M
Bristol Myers Squibb BMY:US $ 9.32B 13.58B
Coherus Biosciences CHRS:US $ 250.39M 156.4M
Eli Lilly And LLY:US $ 5650.3M 202.4M
Gilead Sciences GILD:US $ 3533M 1237M
Glaxosmithkline GSK:US 5.72B 1.95B
GlaxoSmithKline GSK:LN 5.72B 1.95B
Intercept Pharmaceuticals ICPT:US $ 111.01M 12.86M
Johnson & Johnson JNJ:US $ 16.65B 1.76B
Merk MRK:US $ 9038M 5726M
Moderna Inc MRNA:US 671M 174.78M
Neurocrine Biosciences NBIX:US $ 205.1M 10.6M
Novartis NOVN:VX 10.28B 107M
Pfizer PFE:US $ 9065M 2442M
Ptc Therapeutics PTCT:US $ 216.09M 852K
Puma Biotechnology PBYI:US $ 78.21M 14.35M
Regeneron Pharmaceuticals REGN:US $ 1416M 160.1M
Sangamo Biosciences SGMO:US $ 72.58M 3.35M
Sarepta Therapeutics SRPT:US $ 298.8M 17.06M
Teva Pharmaceutical Industries TEVA:US 3.55B 500M
United Therapeutics UTHR:US $ 443.9M 124.3M
Vertex Pharmaceuticals VRTX:US $ 836.48M 45.55M
YTE INCY:US $ 505.92M 119.36M